Therapeutic - Dose LMWH Cuts Thromboembolism, Deaths in COVID - 19
Reduction in venous thromboembolism, arterial thromboembolism, and deaths seen in high - risk patients in non - ICU, but not ICU, settings (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 15, 2021 Category: Respiratory Medicine Tags: Infections, Internal Medicine, Critical Care, Nursing, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news
D-dimer Unreliable for Ruling Out PE in COVID-19 D-dimer Unreliable for Ruling Out PE in COVID-19
Plasma d-dimer levels to rule out pulmonary embolism in hospitalized COVID-19 patients is not the right assay to use, new research suggests. Most patients already have levels greater than 0.05 μg/mL.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - October 13, 2021 Category: Internal Medicine Tags: Cardiology News Source Type: news
Home Management or Hospital Admission for Low-risk PE? Home Management or Hospital Admission for Low-risk PE?
Can clinical prediction models reliably triage patients with acute pulmonary embolism for home vs. hospital treatment?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 13, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Hypercoagulability and Thrombosis in COVID-19 Hypercoagulability and Thrombosis in COVID-19
A new study provides valuable insights into the manifestations of pulmonary embolism in patients with COVID-19, and may help clarify the routine use of anticoagulant strategies in COVID-19 patients.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 11, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
CTPA doesn't necessarily improve usual care for PE diagnosis
Adding CT pulmonary angiography (CTPA) doesn't necessarily improve the usua...Read more on AuntMinnie.comRelated Reading:
AI may not be ready to assess for pulmonary embolism
Chest CT, stress testing find PE in 25% of COVID-19 patients
Exposure to contrast on CTPA doesn't cause long-term kidney injury
Thoracic CT shows promise for monitoring health of obese patients
CTPA shows promise as a PE predictor in COPD patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 5, 2021 Category: Radiology Source Type: news
Physicians Less Likely to Test for PE in Dementia Patients
Findings seen in patients with dementia presenting with clinical factors known to be predictive of pulmonary embolism risk (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 1, 2021 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Emergency Medicine, Neurology, Pathology, Pulmonology, Geriatrics, Journal, Source Type: news
New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the U.S. F...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Winners crowned in machine learning-for-COVID challenge at C-MIMI
The winning teams have been announced in a challenge to develop machine-learnin...Read more on AuntMinnie.comRelated Reading:
FDA faces research hurdles in regulating AI for imaging
Will AI help radiologists survive the data deluge?
SIIM, RSNA, others partner on COVID-19 AI challenge
MIDRC offers support for COVID-19 AI
RSNA announces pulmonary embolism challenge winners (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 21, 2021 Category: Radiology Source Type: news
Blood clot symptoms: The marking on your leg that could signal deep vein thrombosis
DEEP vein thrombosis occurs when a blood clot forms in a deep vein, usually in a person's leg. A pulmonary embolism happens when the blood clot breaks off and travels from the leg up to the lungs. This means it is important to be aware of the signs on your leg. (Source: Daily Express - Health)
Source: Daily Express - Health - September 15, 2021 Category: Consumer Health News Source Type: news
Comparison of three interventional approaches to prevent ventilator-associated pneumonia in intensive care units (ICUs): A clinical trial study
Background: Ventilator-associated pneumonia (VAP) is an infectious pulmonary disease that develops after 48 hours of ventilation. To date, several methods have been proposed to reduce VAP occurrence, such as the VAP prevention bundle, which involves raising the head of the bed, reducing sedation, avoiding deep vein thrombosis, and preventing peptic ulcer in the gastrointestinal system. The purpose of this study was to evaluate the role of personnel in hand washing, case airway suctioning, and systematic monitoring in the prevention of VAP.; Methods: In the current clinical trial, 129 patients hospitalized and intubated at ...
Source: Current Awareness Service for Health (CASH) - September 9, 2021 Category: Consumer Health News Source Type: news
FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) events in p...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
AI may not be ready to assess for pulmonary embolism
An artificial intelligence (AI) algorithm can't be relied upon -- yet -- t...Read more on AuntMinnie.comRelated Reading:
Will AI help radiologists survive the data deluge?
Exposure to contrast on CTPA doesn't cause long-term kidney injury
CTPA shows promise as a PE predictor in COPD patients
Almost 40% of CTPA exams find PE in COVID-19 patients
Why are doctors overriding CT guidelines for PE patients? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 9, 2021 Category: Radiology Source Type: news
Behcet's Syndrome Presenting With Pulmonary Artery Thrombosis Behcet's Syndrome Presenting With Pulmonary Artery Thrombosis
This case demonstrates how early detection of vascular involvement can have a major impact on the prognosis of patients with Behcet ' s syndrome.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 5, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic(TM) Endovascular System
Study is first to compare interventional therapy in combination with anticoagulation to anticoagulation alone for treatment of pulmonary embolism
MARLBOROUGH, Mass., Aug. 4, 2021 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporatio... Devices, Interventional Boston Scientific, EkoSonic , pulmonary embolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 4, 2021 Category: Pharmaceuticals Source Type: news
Chest CT, stress testing find PE in 25% of COVID-19 patients
A quarter of patients hospitalized with COVID-19 show pulmonary embolism (PE...Read more on AuntMinnie.comRelated Reading:
Reduced-dose CT effective for lung nodules in kids
Through COVID-19 pandemic, CT has shown high diagnostic accuracy
Researchers report on PET/CT's COVID-19 pandemic performance
AI-based program helps follow up incidental lung nodules on CT
Deep-learning algorithm estimates cancer risk of pulmonary nodules (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 13, 2021 Category: Radiology Source Type: news
